ROLE SUMMARY
Responsible for conducting statistical analyses primarily on large scale, high-dimensional human genetics datasets, such as GWAS and exome sequencing dataset, and for integrating these results with public datasets and biological knowledge databases in order to make inferences informing therapeutic targeting strategies and patient selection. Additional responsibilities will include analysis of clinical outcomes by pre-defined genetic markers. The candidate will ultimately be responsible for ensuring sound statistical thinking and methods are utilized for the design, analysis, and statistical interpretation of such studies, focused on genetics and 'omics datasets utilized by therapeutic areas across Pfizer’s R&D unit.
ROLE RESPONSIBILITIES
Collaborate with various scientists in the design, analysis and reporting of genetics and ‘omics data, including statistical interpretation of published or internally generated results in order to inform decision-making and identify new targets.
Core member of scientific teams responsible for determining strategy and delivering results in a timely and high-quality environment.
Interact with integrative biology leads, pharmacogenomics leads, and external experts to assure sound quantitative approaches are applied to data collection and analysis.
Provide mentoring and guidance to clinical statisticians on aspects of pharmacogenomics in clinical trials.
Ensure rigorous approaches are taken to ensure good scientific practices are followed: excellent statistical methods utilized and documented in protocols, analysis plans and manuscripts, and assay methods are appropriately blinded, randomized and designed to meet clear objectives.
Integrate genetics across clinical trials in order to make inferences related to personalized medicine using appropriate meta-analysis techniques.
Integrate genetics across public resources in order to make inferences related to portfolio prioritization and new target identification.
Use statistical expertise to influence both internal and external reports and presentations, with the aim to improve the quality of internal decision making and increase our influence on the external environment.
QUALIFICATIONS
PhD in Statistics or related computational field, or demonstration of sufficient statistical training to be successful in the position including experience or academic training in statistical genetics
At least one full year experience applying statistical methods to scientific and/or clinical problems. Pharmaceutical or biotech applications desired.
Demonstrated skill manipulating large datasets and automating such tasks.
Demonstrated understanding of GWAS and sequence-based analysis.
Familiarity/expertise in meta-analysis and potential issues surrounding combining results from different studies, both from a design perspective and in terms of subject ascertainment.
Experience with multivariate statistics and statistical methods to quantify uncertainty in multi-dimensional data, and with QC procedures for GWAS and sequencing data.
Demonstrated strong communication skills, both oral and written.
Demonstrated ability to work effectively as a part of a team.
Must be able to explain statistical techniques and considerations to non-statisticians
TECHNICAL SKILL REQUIREMENTS
Must have R or SAS programming skills and familiarity with a Linux/UNIX environment
Knowledge or proficiency in PLINK, ability to use genetic imputation software such as MACH, IMPUTE, Minimac, or imputation servers such a UMich or TopMed, and awareness of the latest techniques in sequence-based analysis and other genetics tools will be extremely helpful
New York, New York
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names.
Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.